Literature DB >> 18976362

Topical treatment of uveitis resulting in adrenal insufficiency.

Liisa Kröger1, Kaisu Kotaniemi, Jarmo Jääskeläinen.   

Abstract

UNLABELLED: The adverse effects of corticosteroids are well-known and occur more frequently when corticosteroids are used perorally or intravenously. The management of uveitis, which normally consists of topical corticosteroids and mydriates, can be challenging. We report a case in which continuous use of topical corticosteroids resulted in adrenal insufficiency and obesity.
CONCLUSION: When topical corticosteroids are used over longer periods, hypophysis-pituitary-adrenal (HPA) function should be carefully monitored.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18976362     DOI: 10.1111/j.1651-2227.2008.01091.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  4 in total

Review 1.  The unresolved riddle of glucocorticoid withdrawal.

Authors:  F Guerrero Pérez; A P Marengo; C Villabona Artero
Journal:  J Endocrinol Invest       Date:  2017-05-20       Impact factor: 4.256

2.  Do topical ophthalmic corticosteroids suppress the hypothalmic-pituitary-adrenal axis in post-penetrating keratoplasty patients?

Authors:  S S Sandhu; J M Smith; M Doherty; A James; F C Figueiredo
Journal:  Eye (Lond)       Date:  2012-02-17       Impact factor: 3.775

Review 3.  Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.

Authors:  A Heiligenhaus; H Michels; C Schumacher; I Kopp; U Neudorf; T Niehues; H Baus; M Becker; B Bertram; G Dannecker; C Deuter; I Foeldvari; M Frosch; G Ganser; M Gaubitz; G Gerdes; G Horneff; A Illhardt; F Mackensen; K Minden; U Pleyer; M Schneider; N Wagner; M Zierhut
Journal:  Rheumatol Int       Date:  2011-11-15       Impact factor: 2.631

Review 4.  Cataract management in children: a review of the literature and current practice across five large UK centres.

Authors:  J E Self; R Taylor; A L Solebo; S Biswas; M Parulekar; A Dev Borman; J Ashworth; R McClenaghan; J Abbott; E O'Flynn; D Hildebrand; I C Lloyd
Journal:  Eye (Lond)       Date:  2020-08-10       Impact factor: 3.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.